1,468
Views
32
CrossRef citations to date
0
Altmetric
Review

Alcohol addiction - the safety of available approved treatment options

, , , , , , , ORCID Icon, & ORCID Icon show all
Pages 169-177 | Received 18 Jul 2017, Accepted 07 Nov 2017, Published online: 20 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Hugo López-Pelayo, Paola Zuluaga, Elsa Caballeria, Wim Van den Brink, Karl Mann & Antoni Gual. (2020) Safety of nalmefene for the treatment of alcohol use disorder: an update. Expert Opinion on Drug Safety 19:1, pages 9-17.
Read now
M S Zastrozhin, V Yu Skryabin, S S Miroshkin, E A Bryun & D A Sychev. (2019) Pharmacogenetics of alcohol addiction: current perspectives. The Application of Clinical Genetics 12, pages 131-140.
Read now
Wenjun Wang, Ying Xu, Chang Jiang & Yanhang Gao. (2019) Advances in the treatment of severe alcoholic hepatitis. Current Medical Research and Opinion 35:2, pages 261-273.
Read now

Articles from other publishers (29)

Akshay Shetty, Brittney Ibrahim, Benjamin Eskander & Sammy Saab. (2023) Management of Patients After Treatment of Severe Alcohol-associated Hepatitis. Journal of Clinical Gastroenterology.
Crossref
Majid Davidson, Niloufar Rashidi, Md Kamal Hossain, Ali Raza, Kulmira Nurgali & Vasso Apostolopoulos. (2023) Tryptophan and Substance Abuse: Mechanisms and Impact. International Journal of Molecular Sciences 24:3, pages 2737.
Crossref
Antonio Mirijello, Luisa Sestito, Christian Lauria, Claudia Tarli, Gabriele Angelo Vassallo, Mariangela Antonelli, Cristina d'Angelo, Anna Ferrulli, Filippo Crea, Anthony Cossari, Lorenzo Leggio, Salvatore De Cosmo, Antonio Gasbarrini & Giovanni Addolorato. (2022) Echocardiographic markers of early alcoholic cardiomyopathy: Six-month longitudinal study in heavy drinking patients. European Journal of Internal Medicine 101, pages 76-85.
Crossref
Gianni Testino, Teo Vignoli, Valentino Patussi, Pierluigi Allosio, Maria Francesca Amendola, Sarino Aricò, Aniello Baselice, Patrizia Balbinot, Vito Campanile, Tiziana Fanucchi, Giovanni Greco, Livia Macciò, Cristina Meneguzzi, Davide Mioni, Vincenzo Ostilio Palmieri, Michele Parisi, Doda Renzetti, Raffaella Rossin, Claudia Gandin, Luigi Carlo Bottaro, Mauro Bernardi, Giovanni Addolorato, Lisa Lungaro, Giorgio Zoli, Emanuele Scafato & Fabio Caputo. (2021) Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA). Digestive Diseases and Sciences 67:6, pages 1975-1986.
Crossref
Diego Zapelini do Nascimento, Gabriela Moreno Marques & Fabiana Schuelter-Trevisol. (2022) Potential interactions between psychotropic drugs and alcohol and tobacco dependence. Brazilian Journal of Pharmaceutical Sciences 58.
Crossref
Miriam Beatriz Virgolini & Ricardo Marcos Pautassi. 2022. Neurotoxicity of Drugs of Abuse. Neurotoxicity of Drugs of Abuse 49 92 .
Hitoshi Yoshiji, Tadashi Namisaki, Kosuke Kaji & Sven Francque. 2022. Portal Hypertension VII. Portal Hypertension VII 221 238 .
Flavia V. Stefanello, Talise E. Müller, Francini Franscescon, Vanessa A. Quadros, Thiele P. Souza, Julia Canzian, Jossiele Leitemperger, Vania L. Loro & Denis B. Rosemberg. (2021) Taurine modulates behavioral effects of intermittent ethanol exposure without changing brain monoamine oxidase activity in zebrafish: Attenuation of shoal- and anxiety-like responses, and abolishment of memory acquisition deficit. Pharmacology Biochemistry and Behavior 209, pages 173256.
Crossref
Julia Kim, Anmol Taggar, Lena C. Quilty, Peter Selby, Fernando Caravaggio, Fumihiko Ueno, Jianmeng Song, Bruce G. Pollock, Ariel Graff-Guerrero & Philip Gerretsen. (2021) A measure of illness awareness in alcohol use disorder—Alcohol Use Awareness and Insight Scale (AAS). Drug and Alcohol Dependence 226, pages 108813.
Crossref
Milja Heikkinen, Heidi Taipale, Antti Tanskanen, Ellenor Mittendorfer‐Rutz, Markku Lähteenvuo & Jari Tiihonen. (2021) Real‐world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation‐wide cohort of 125 556 patients. Addiction 116:8, pages 1990-1998.
Crossref
Narendra S. Choudhary, Neeraj Saraf, Saurabh Mehrotra, Sanjiv Saigal & Arvinder S. Soin. (2021) Recidivism in Liver Transplant Recipients for Alcohol-related Liver Disease. Journal of Clinical and Experimental Hepatology 11:3, pages 387-396.
Crossref
Robert W. Kirchoff, Norhan M. Mohammed, Jack McHugh, Matej Markota, Thomas Kingsley, Jonathan Leung, M. Caroline Burton & Rahul Chaudhary. (2021) Naltrexone Initiation in the Inpatient Setting for Alcohol Use Disorder: A Systematic Review of Clinical Outcomes. Mayo Clinic Proceedings: Innovations, Quality & Outcomes 5:2, pages 495-501.
Crossref
L. Parker Gregg & S. Susan Hedayati. 2021. Psychosocial Aspects of Chronic Kidney Disease. Psychosocial Aspects of Chronic Kidney Disease 91 116 .
Brendan Smyth, Anna Haber & Annemarie Hennessy. 2021. Textbook of Addiction Treatment. Textbook of Addiction Treatment 1113 1132 .
Dre Lisa Graves, Dr George Carson, Nancy Poole, Dre Tejal Patel, Jodie Bigalky, Courtney R. Green & Jocelynn L. Cook. (2020) Directive clinique no 405 : Dépistage et conseils en matière de consommation d'alcool pendant la grossesse. Journal of Obstetrics and Gynaecology Canada 42:9, pages 1174-1192.e1.
Crossref
Lisa Graves, George Carson, Nancy Poole, Tejal Patel, Jodie Bigalky, Courtney R. Green & Jocelynn L. Cook. (2020) Guideline No. 405: Screening and Counselling for Alcohol Consumption During Pregnancy. Journal of Obstetrics and Gynaecology Canada 42:9, pages 1158-1173.e1.
Crossref
Talise E. Müller, Barbara D. Fontana, Kanandra T. Bertoncello, Francini Franscescon, Nathana J. Mezzomo, Julia Canzian, Flavia V. Stefanello, Matthew O. Parker, Robert Gerlai & Denis B. Rosemberg. (2020) Understanding the neurobiological effects of drug abuse: Lessons from zebrafish models. Progress in Neuro-Psychopharmacology and Biological Psychiatry 100, pages 109873.
Crossref
Deepak Chouhan, Ankit Uniyal, Anagha Gadepalli, Akhilesh, Vineeta Tiwari, Somesh Agrawal, Tapas Kumar Roy, Sneha Shaw, Narendra Purohit & Vinod Tiwari. (2020) Probing the Manipulated Neurochemical Drive in Alcohol Addiction and Novel Therapeutic Advancements. ACS Chemical Neuroscience 11:9, pages 1210-1217.
Crossref
Giovanni Addolorato, Ludovico Abenavoli, Marcello Dallio, Alessandro Federico, Giacomo Germani, Stefano Gitto, Gioacchino Leandro, Carmelina Loguercio, Fabio Marra & Elisa Stasi. (2020) Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF). Digestive and Liver Disease 52:4, pages 374-391.
Crossref
Khushboo S. Gala & Vatsalya Vatsalya. (2020) Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope. Cells 9:3, pages 524.
Crossref
L. Parker Gregg & S. Susan Hedayati. 2020. Chronic Renal Disease. Chronic Renal Disease 1123 1140 .
Bhavani Kashyap, Leah R. Hanson & William H. Frey II. (2020) Intranasal Insulin: a Treatment Strategy for Addiction. Neurotherapeutics 17:1, pages 105-115.
Crossref
Oren Even-Chen & Segev Barak. (2019) Inhibition of FGF Receptor-1 Suppresses Alcohol Consumption: Role of PI3 Kinase Signaling in Dorsomedial Striatum. The Journal of Neuroscience 39:40, pages 7947-7957.
Crossref
Girdhari Lal Gupta & Lalit Sharma. (2019) Bacopa monnieri abrogates alcohol abstinence-induced anxiety-like behavior by regulating biochemical and Gabra1, Gabra4, Gabra5 gene expression of GABAA receptor signaling pathway in rats. Biomedicine & Pharmacotherapy 111, pages 1417-1428.
Crossref
Marco Diana, Corinna Bolloni, Mariangela Antonelli, Daniela Di Giuda, Fabrizio Cocciolillo, Liana Fattore & Giovanni Addolorato. (2019) Repetitive transcranial magnetic stimulation: Re-wiring the alcoholic human brain. Alcohol 74, pages 113-124.
Crossref
Muhammad A. Alsherbiny, Wessam H. Abd-Elsalam, Shymaa A. El badawy, Ehab Taher, Mohamed Fares, Allan Torres, Dennis Chang & Chun Guang Li. (2019) Ameliorative and protective effects of ginger and its main constituents against natural, chemical and radiation-induced toxicities: A comprehensive review. Food and Chemical Toxicology 123, pages 72-97.
Crossref
Gianni Testino, Luigi C. Bottaro, Valentino Patussi, Emanuele Scafato, Giovanni Addolorato, Silvia Leone, Doda Renzetti, Patrizia Balbinot, Giovanni Greco, Tiziana Fanucchi, Giorgio Schiappacasse, Paola Cardinale, Pierluigi Allosio, Rinaldo Pellicano & Fabio Caputo. (2018) Addiction disorders: a need for change. Proposal for a new management. Position paper of SIA, Italian Society on Alcohol. Minerva Medica 109:5.
Crossref
M. Carmen Blanco-Gandía & Marta Rodríguez-Arias. (2018) Pharmacological treatments for opiate and alcohol addiction: A historical perspective of the last 50 years. European Journal of Pharmacology 836, pages 89-101.
Crossref
Bruk Getachew, Tamaro Hudson, Thomas Heinbockel, Antonei B. Csoka & Yousef Tizabi. (2018) Protective Effects of Donepezil Against Alcohol-Induced Toxicity in Cell Culture: Role of Caspase-3. Neurotoxicity Research 34:3, pages 757-762.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.